The CK 1ε/ SIAH1 axis regulates AXIN 1 stability in colorectal cancer cells
Molecular Oncology · 2024
DOI: 10.1002/1878-0261.13624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Mengfang Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Regional Immunity and Disease, International Cancer Center, Marshall Laboratory of Biomedical Engineering, Dep…. Hauptthemen laut MEDLINE: Axin Protein, Colorectal Neoplasms, Casein Kinase 1 epsilon, Ubiquitin-Protein Ligases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Program, Shenzhen Key Basic Research Program, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Casein kinase 1ε (CK1ε) and axis inhibitor 1 (AXIN1) are crucial components of the β‐catenin destruction complex in canonical Wnt signaling. CK1ε has been shown to interact with AXIN1, but its physiological function and role in tumorigenesis remain unknown. In this study, we found that CK1δ/ε inhibitors significantly enhanced AXIN1 protein level in colorectal cancer (CRC) cells through targeting CK1ε. Mechanistically, CK1ε promoted AXIN1 degradation by the ubiquitin–proteasome pathway by promoting the interaction of E3 ubiquitin‐protein ligase SIAH1 with AXIN1. Genetic or pharmacological inhibition of CK1ε and knockdown of SIAH1 downregulated the expression of Wnt/β‐catenin‐dependent genes, suppressed the viability of CRC cells, and restrained tumorigenesis and progression of CRC in vitro and in vivo . In summary, our results demonstrate that CK1ε exerted its oncogenic role in CRC occurrence and progression by regulating the stability of AXIN1. These findings reveal a novel mechanism by which CK1ε regulates the Wnt/β‐catenin signaling pathway and highlight the therapeutic potential of targeting the CK1ε/SIAH1 axis in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Regional Immunity and Disease, International Cancer Center, Marshall Laboratory of Biomedical Engineering, Department of Pharmacology, Shenzhen University Medical School, Shenzhen…
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University, China.
- Department of Research, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
- Medical Scientific Research Center, Life Sciences Institute, Guangxi Medical University, Nanning, China.
ORCID-Profile: Xibao Zhao, Desheng Lu
Förderung
- Shenzhen Science and Technology Innovation Program
- Shenzhen Key Basic Research Program
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- Stable Support Project of Shenzhen
Zitieren
APA
Yan, M., Su, Z., Pang, X., Wang, H., Dai, H., Ning, J., Liu, S., Sun, Q., Song, J., Zhao, X., & Lu, D. (2024). The CK 1ε/ SIAH1 axis regulates AXIN 1 stability in colorectal cancer cells. Molecular Oncology. https://doi.org/10.1002/1878-0261.13624
Vancouver
Yan M, Su Z, Pang X, Wang H, Dai H, Ning J, et al. The CK 1ε/ SIAH1 axis regulates AXIN 1 stability in colorectal cancer cells. Molecular Oncology. 2024. doi:10.1002/1878-0261.13624
BibTeX
@article{Yan2024,
author = {Yan, Mengfang and Su, Zijie and Pang, Xiaoyi and Wang, Hanbin and Dai, Han and Ning, Jiong and Liu, Shanshan and Sun, Qi and Song, Jiaxing and Zhao, Xibao and Lu, Desheng},
title = {The CK 1ε/ SIAH1 axis regulates AXIN 1 stability in colorectal cancer cells},
journal = {Molecular Oncology},
year = {2024},
doi = {10.1002/1878-0261.13624}
}
EUVIMED